$ 5.99 Antimicrobial Susceptibility Testing Marketplace

Redding, Calif., October 5, 2021 (GLOBE NEWSWIRE) – According to a new market research report titled,Antimicrobial Susceptibility Testing Market by product (manual {sensitivity discs, plates, MIC strips}, consumables, automated), method (diffusion, dilution), application (clinical diagnostics), end user (hospitals, pharmacy, institutes) – Forecast until 2028 ”, published by Meticulous Research®, the antimicrobial susceptibility testing market is expected to grow at a CAGR of 6.4% from 2021 to 2028 to reach $ 5.99 billion by 2028.

Download a Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5062

Antimicrobial susceptibility testing (AST) is one of the vital tasks performed in clinical microbiology laboratories. The main objective of these tests is to detect possible drug resistance in common pathogens and to ensure sensitivity to the drugs of choice for a particular type of infection. In recent years, increasing resistance to antibiotics has led to a growing demand for antimicrobial susceptibility testing. The growth of this market is mainly attributed to the high prevalence of infectious diseases, the development of automated and manual products for AST, the increase in government initiatives and funding of AST programs, technological advancements towards the development of new AST methods and the emergence of multidrug resistance. in microorganisms. Emerging markets and active R&D to develop rapid antimicrobial susceptibility testing are expected to offer significant growth opportunities for players operating in the antimicrobial susceptibility testing market. However, strict government regulations are expected to hamper the growth of this market to some extent. On the other hand, the high cost of automated antimicrobial susceptibility testing systems and the problems of antimicrobial resistance surveillance in low- and middle-income countries pose challenges for the industry.

The overall antimicrobial susceptibility testing market is segmented on the basis of product, method, application, end use, and geography.

Talk to our analysts to understand the impact of COVID-19 on your business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5062

Based on the product, the antimicrobial susceptibility testing market is segmented into manual AST products, automated AST products, and consumables. In 2021, the manual AST products segment is expected to account for the largest share of the overall antimicrobial susceptibility testing market. The growth of this market is due to the inexpensive nature of manual AST products, the simple handling procedures of these products, the increasing incidence of antibacterial resistance, the availability of a diverse range of consumables for manual testing. and the ease of interpretation of these tests.

On the basis of the method, the antimicrobial susceptibility testing market is segmented into disk diffusion, automated AST, dilution, and other methods. In 2021, the disk delivery segment is expected to account for the largest share of the overall antimicrobial susceptibility testing market. The advantages of the disk diffusion method are the simplicity of the test which does not require any special equipment, the provision of categorical results easily interpreted by any clinician and the flexibility in the selection of the disks to be tested. The low cost of AST tests with the disk diffusion methods and the method developments with automated technology are mainly driving the market growth of the segment.

Based on the applications, the antimicrobial susceptibility testing market is segmented into clinical diagnostics, drug discovery and development, and other applications. In 2021, the clinical diagnostics segment is expected to represent the largest share of the global antimicrobial susceptibility testing market. The large share is mainly attributed to the growing burden of antibiotic resistance, the increasing incidence of HAIs, the increasing volume of clinical diagnostic testing procedures, the increasing emphasis on the effective and early diagnosis of diseases on major markets and increasing physician awareness of antimicrobial susceptibility testing methods. .

Quick purchase – Antimicrobial Susceptibility Testing Market Research Report: https://www.meticulousresearch.com/Checkout/14616729

Based on the end user, the antimicrobial susceptibility testing market is segmented into diagnostic laboratories and hospitals, pharmaceutical and biotechnology companies, and research institutes and academics. In 2021, the diagnostic laboratory and hospital segment is expected to account for the largest share of the overall antimicrobial susceptibility testing market. The large share of this segment is mainly attributed to the availability of well-equipped facilities and trained / competent technicians and the increase in cases of nosocomial infections.

On the basis of geography, the global antimicrobial susceptibility testing market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa. In 2021, North America is estimated to account for the largest share of the global antimicrobial susceptibility testing market, followed by Europe and Asia-Pacific. The significant share of the North American region is attributed to increased healthcare spending, increased investment in pharmaceutical R&D, and the availability of advanced susceptibility testing methods. However, Asia Pacific is expected to grow at the highest CAGR of 8.4% due to increasing cases of antibiotic resistance and heightened awareness of antimicrobial susceptibility testing.

Some of the major players operating in the global antimicrobial susceptibility testing market include Merck KGaA (Germany), bioMérieux SA (France), HiMedia Laboratories Pvt. Ltd. (India), MERLIN Diagnostika GmbH (Germany), Alifax Srl (Italy), Synbiosis (UK) and Zhuhai DL Biotech Co., Ltd (China) among others. New product launches, enhancements, approvals and agreements are some of the key strategies adopted by players to expand their service offerings, global footprint and increase market share. For example, in July 2020, the company launched Xpert MTB / XDR, a rapid molecular test for tuberculosis, and detects resistance to first and second-line drugs. Likewise, in October 2019, Becton, Dickinson and Company (US), as well as Check-Points Health BV (Netherlands), received 510 (k) clearance from the FDA for a molecular screening test for Antibiotic Resistant Carbapenemase (OPC) Producing Organisms on the Fully Automated BD MAX System. The BD MAX Check-Points CPO Assay enables detection of carbapenemase genes directly from patient samples and improved turnaround time.

To better understand the market with a table of contents and detailed figures, click here: https://www.meticulousresearch.com/product/antimicrobial-susceptibility-testing-market-5062

Scope of the report:

Antimicrobial Susceptibility Testing Market, by product

  • Manual Antimicrobial Susceptibility Testing Products
    • Sensitivity discs
    • Susceptibility plates
    • Minimum Inhibitory Concentration (MIC) strips
  • Consumables
  • Automated Antimicrobial Susceptibility Testing Products

Antimicrobial Susceptibility Testing Market, By Method

  • Diffusion Disc
  • Automated AST
  • Dilution
  • Other methods

Other methods include Etest, genotypic methods, and MALDI-TOF MS.

Antimicrobial Susceptibility Testing Market, By Application

  • Clinical diagnosis
  • Drug discovery and development
  • Other applications

(Other applications include epidemiology, veterinary diagnostics, and environmental monitoring)

Antimicrobial Susceptibility Testing Market, By End User

  • Diagnostic laboratories and hospitals
  • Pharmaceutical and biotechnology companies
  • Research institutes and universities

Antimicrobial Susceptibility Testing Market, by geography

  • North America
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East and Africa

Download a Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5062

In the midst of this crisis, Meticulous Research® Continuously assesses the impact of the COVID-19 pandemic on various submarkets and enables global organizations to strategize for the post-COVID-19 world and support their growth. Let us know if you would like to assess the impact of COVID-19 on any industry here- https://www.meticulousresearch.com/custom-research

Associated reports

Blood Screening Market by Product (Reagents and Kits, Instruments, Software), Technology (NAAT [Real-time PCR], ELISA [CLIA, FIA, CI], rapid tests, Western Blot, NGS) and end user (blood banks, hospitals, laboratories) – Global forecast to 2027

https://www.meticulousresearch.com/product/blood-screening-market-5164

Infectious disease diagnostics market by product and solution (consumables, system, software and services), technology (immunodiagnostics, PCR, INAAT), disease (HIV, HAIS, influenza), end user (hospital, reference laboratory, research) – Global forecasts for 2027

https://www.meticulousresearch.com/product/infectious-disease-diagnostics-market-4976

About Meticulous Research®

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a limited liability company under the Companies Act of 1956. Since its incorporation, the company has grown into the leading provider of high-end market information in North America, Europe, Asia- Pacific, Latin America, Middle East and Africa. .

The name of our company defines our services, our strengths and our values. From the beginning, we have only made an effort to research, analyze and present critical market data with great attention to detail. Through meticulous primary and secondary research techniques, we have developed strong capabilities in data collection, interpretation and analysis, including qualitative and quantitative research with the best team of analysts. We design our market research reports, personalized studies, rapid research and consulting solutions, intelligent and value-driven, meticulously analyzed to meet the business challenges of sustainable growth.

Contact:
Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis Street, 200 Redding Street,
California, 96001, United States
United States: + 1-646-781-8004
Europe: + 44-203-868-8738
APAC: +91 744-7780008
E-mail- [email protected]
Visit our website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Source of content: https://www.meticulousresearch.com/pressrelease/78/antimicrobial-susceptibility-testing-market-2028


Source link

About William W.

Check Also

Hertz files for new IPO

By Chris Isidore, CNN Business Hertz becomes public again. The car rental company, which filed …